Skip to main content
Erschienen in: Journal of Hematopathology 3/2013

01.09.2013 | Case Report

Diffuse variant of lymphocyte-predominant Hodgkin lymphoma: a diagnostic challenge

verfasst von: Yuanming Zhang, Ihsane Ouansafi, Wayne Tam, John P. Leonard, Attilio Orazi

Erschienen in: Journal of Hematopathology | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

The diffuse variant of nodular lymphocyte-predominant Hodgkin lymphoma (D-LPHL) is exceedingly rare. Here we report a case of D-LPHL in a 35-year-old Caucasian female who presented with left cervical and right axillary lymphadenopathy. Histopathologic examination reveals large atypical lymphoid cells resembling lymphocyte-predominant (LP) cells in a background of reactive T cells, B cells, and histiocytes. Extensive immunohistochemical study demonstrates that these large atypical lymphoid cells express characteristic phenotype of LP cells including CD20, CD79a, BOB-1, OCT-2, BCL-6, and EMA and are negative for CD30 and fascin. The diffuse nature of the lymphoid proliferation is confirmed by negative CD21, CD23, and CD35 stains showing a complete lack of follicular dendritic cell meshworks. The associated T cell microenvironment shows increased CD57(+) T cells arranged into peritumoral cell rosettes. The diagnostic criteria of this case are discussed and a review of the literature about the differential diagnosis is provided.
Literatur
1.
Zurück zum Zitat Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer, Lyon Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer, Lyon
2.
Zurück zum Zitat Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA (2003) Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol 27:1346–1356PubMedCrossRef Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA (2003) Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol 27:1346–1356PubMedCrossRef
3.
Zurück zum Zitat Anagnostopoulos I, Hansmann ML, Franssila K, Harris M, Harris NL, Jaffe ES, Han J, van Krieken JM, Poppema S, Marafioti T, Franklin J, Sextro M, Diehl V, Stein H (2000) European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 96:1889–1899PubMed Anagnostopoulos I, Hansmann ML, Franssila K, Harris M, Harris NL, Jaffe ES, Han J, van Krieken JM, Poppema S, Marafioti T, Franklin J, Sextro M, Diehl V, Stein H (2000) European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 96:1889–1899PubMed
4.
Zurück zum Zitat Pittaluga S, Jaffe ES (2010) T-cell/histiocyte-rich large B-cell lymphoma. Haematologica 95:352–356PubMedCrossRef Pittaluga S, Jaffe ES (2010) T-cell/histiocyte-rich large B-cell lymphoma. Haematologica 95:352–356PubMedCrossRef
5.
Zurück zum Zitat Hansmann ML, Stein H, Dallenbach F, Fellbaum C (1991) Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma): a variant of the B-cell-derived nodular type. Am J Pathol 138:29–36PubMed Hansmann ML, Stein H, Dallenbach F, Fellbaum C (1991) Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma): a variant of the B-cell-derived nodular type. Am J Pathol 138:29–36PubMed
6.
Zurück zum Zitat Poppema S (1992) Lymphocyte-predominance Hodgkin's disease. Semin Diagn Pathol 9:257–264PubMed Poppema S (1992) Lymphocyte-predominance Hodgkin's disease. Semin Diagn Pathol 9:257–264PubMed
7.
Zurück zum Zitat Nam-Cha SH, Montes-Moreno S, Salcedo MT, Sanjuan J, Garcia JF, Piris MA (2009) Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers. Mod Pathol 22:1006–1015PubMedCrossRef Nam-Cha SH, Montes-Moreno S, Salcedo MT, Sanjuan J, Garcia JF, Piris MA (2009) Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers. Mod Pathol 22:1006–1015PubMedCrossRef
8.
Zurück zum Zitat Bhargava P, Pantanowitz L, Pinkus GS, Pinkus JL, Paessler ME, Roullet M, Gautam S, Bagg A, Kadin ME (2010) Utility of fascin and JunB in distinguishing nodular lymphocyte predominant from classical lymphocyte-rich Hodgkin lymphoma. Appl Immunohistochem Mol Morphol 18:16–23PubMedCrossRef Bhargava P, Pantanowitz L, Pinkus GS, Pinkus JL, Paessler ME, Roullet M, Gautam S, Bagg A, Kadin ME (2010) Utility of fascin and JunB in distinguishing nodular lymphocyte predominant from classical lymphocyte-rich Hodgkin lymphoma. Appl Immunohistochem Mol Morphol 18:16–23PubMedCrossRef
9.
Zurück zum Zitat Prakash S, Fountaine T, Raffeld M, Jaffe ES, Pittaluga S (2006) IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma. Am J Surg Pathol 30:585–592PubMedCrossRef Prakash S, Fountaine T, Raffeld M, Jaffe ES, Pittaluga S (2006) IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma. Am J Surg Pathol 30:585–592PubMedCrossRef
10.
Zurück zum Zitat Atayar C, Poppema S, Visser L, van den Berg A (2006) Cytokine gene expression profile distinguishes CD4+/CD57+ T cells of the nodular lymphocyte predominance type of Hodgkin's lymphoma from their tonsillar counterparts. J Pathol 208:423–430PubMedCrossRef Atayar C, Poppema S, Visser L, van den Berg A (2006) Cytokine gene expression profile distinguishes CD4+/CD57+ T cells of the nodular lymphocyte predominance type of Hodgkin's lymphoma from their tonsillar counterparts. J Pathol 208:423–430PubMedCrossRef
11.
Zurück zum Zitat Loo PV, Tousseyn T, Vanhentenrijk V, Dierickx D, Malecka A, Bempt IV, Verhoef G, Delabie J, Marynen P, Matthys P, De Wolf-Peeters C (2010) T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response. Haematologica 95:440–448PubMedCrossRef Loo PV, Tousseyn T, Vanhentenrijk V, Dierickx D, Malecka A, Bempt IV, Verhoef G, Delabie J, Marynen P, Matthys P, De Wolf-Peeters C (2010) T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response. Haematologica 95:440–448PubMedCrossRef
12.
Zurück zum Zitat Franke S, Wlodarska I, Maes B, Vandenberghe P, Achten R, Hagemeijer A, De Wolf-Peeters C (2002) Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich B-cell lymphoma from nodular lymphocyte predominance Hodgkin's lymphoma. Am J Pathol 161:1861–1867PubMedCrossRef Franke S, Wlodarska I, Maes B, Vandenberghe P, Achten R, Hagemeijer A, De Wolf-Peeters C (2002) Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich B-cell lymphoma from nodular lymphocyte predominance Hodgkin's lymphoma. Am J Pathol 161:1861–1867PubMedCrossRef
13.
Zurück zum Zitat Brune V, Tiacci E, Pfeil I, Döring C, Eckerle S, van Noesel CJM, Klapper W, Falini B, von Heydebreck A, Metzler D, Bräuninger A, Hansmann M-L, Küppers R (2008) Origin and pathogenesis of nodular lymphocyte—predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med 205:2251–2268PubMedCrossRef Brune V, Tiacci E, Pfeil I, Döring C, Eckerle S, van Noesel CJM, Klapper W, Falini B, von Heydebreck A, Metzler D, Bräuninger A, Hansmann M-L, Küppers R (2008) Origin and pathogenesis of nodular lymphocyte—predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med 205:2251–2268PubMedCrossRef
14.
Zurück zum Zitat Jackson C, Sirohi B, Cunningham D, Horwich A, Thomas K, Wotherspoon A (2010) Lymphocyte predominant Hodgkin lymphoma—clinical features and treatment outcomes from a 30-year experience. Ann Oncol 21:2061–2068PubMedCrossRef Jackson C, Sirohi B, Cunningham D, Horwich A, Thomas K, Wotherspoon A (2010) Lymphocyte predominant Hodgkin lymphoma—clinical features and treatment outcomes from a 30-year experience. Ann Oncol 21:2061–2068PubMedCrossRef
15.
Zurück zum Zitat Ripp JA, Loiue DC, Chan W, Nawaz H, Portlock CS (2002) T-cell rich B-cell lymphoma: clinical distinctiveness and response to treatment in 45 patients. Leuk Lymphoma 43:1573–1580PubMedCrossRef Ripp JA, Loiue DC, Chan W, Nawaz H, Portlock CS (2002) T-cell rich B-cell lymphoma: clinical distinctiveness and response to treatment in 45 patients. Leuk Lymphoma 43:1573–1580PubMedCrossRef
Metadaten
Titel
Diffuse variant of lymphocyte-predominant Hodgkin lymphoma: a diagnostic challenge
verfasst von
Yuanming Zhang
Ihsane Ouansafi
Wayne Tam
John P. Leonard
Attilio Orazi
Publikationsdatum
01.09.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Hematopathology / Ausgabe 3/2013
Print ISSN: 1868-9256
Elektronische ISSN: 1865-5785
DOI
https://doi.org/10.1007/s12308-012-0162-8

Weitere Artikel der Ausgabe 3/2013

Journal of Hematopathology 3/2013 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …